Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
FUSE
MCID: PLY150
MIFTS: 29

Polykaryocytosis Inducer (FUSE)

Genes Tissues Related diseases Publications Drugs
Sources

Aliases & Classifications for Polykaryocytosis Inducer

About this section

MalaCards integrated aliases for Polykaryocytosis Inducer:

Name: Polykaryocytosis Inducer 57
Fuse 57

External Ids:

OMIM® 57 174750
Sources

Summaries for Polykaryocytosis Inducer

About this section
MalaCards based summary : Polykaryocytosis Inducer, also known as fuse, is related to spondyloarthropathy 1 and tarsal-carpal coalition syndrome. An important gene associated with Polykaryocytosis Inducer is FUSE (Polykaryocytosis Promoter). The drugs Ranibizumab and Midazolam have been mentioned in the context of this disorder. Affiliated tissues include brain, bone and skeletal muscle.

More information from OMIM: 174750
Sources

Related Diseases for Polykaryocytosis Inducer

About this section

Diseases related to Polykaryocytosis Inducer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 96)
# Related Disease Score Top Affiliating Genes
1 spondyloarthropathy 1 11.1
2 tarsal-carpal coalition syndrome 11.0
3 ring chromosome 20 11.0
4 ankyloblepharon-ectodermal defects-cleft lip/palate 10.9
5 aortic valve disease 1 10.9
6 wildervanck syndrome 10.9
7 bifid nose with or without anorectal and renal anomalies 10.9
8 ring chromosome 14 syndrome 10.9
9 bladder exstrophy-epispadias-cloacal exstrophy complex 10.9
10 craniosynostosis 10.9
11 horseshoe kidney 10.9
12 iniencephaly 10.9
13 ring chromosome 13 10.9
14 ring chromosome 15 10.9
15 spondylolisthesis 10.2
16 adenoma 10.2
17 back pain 10.2
18 sudden infant death syndrome 10.1
19 immune deficiency disease 10.0
20 rett syndrome 10.0
21 hepatitis c virus 10.0
22 scoliosis 10.0
23 cholera 10.0
24 hepatitis c 10.0
25 influenza 10.0
26 stomatitis 10.0
27 hypoxia 10.0
28 optic atrophy 1 9.9
29 schizophrenia 9.9
30 scoliosis, isolated 1 9.9
31 human immunodeficiency virus type 1 9.9
32 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.9
33 colorectal adenoma 9.9
34 idiopathic scoliosis 9.9
35 hepatitis 9.9
36 liver cirrhosis 9.9
37 spinal stenosis 9.9
38 chronic pain 9.9
39 achondroplasia 9.8
40 bladder cancer 9.8
41 colorectal cancer 9.8
42 fibrosis of extraocular muscles, congenital, 1 9.8
43 gray platelet syndrome 9.8
44 hair whorl 9.8
45 ovarian cancer 9.8
46 prostate cancer 9.8
47 small cell cancer of the lung 9.8
48 storage pool platelet disease 9.8
49 bloom syndrome 9.8
50 myeloma, multiple 9.8

Graphical network of the top 20 diseases related to Polykaryocytosis Inducer:



Diseases related to Polykaryocytosis Inducer
Sources

Symptoms & Phenotypes for Polykaryocytosis Inducer

About this section

Clinical features from OMIM®:

174750 (Updated 05-Mar-2021)

Sources

Drugs & Therapeutics for Polykaryocytosis Inducer

About this section

Drugs for Polykaryocytosis Inducer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 80)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ranibizumab Approved Phase 4 347396-82-1 459903
2
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
3
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
4 Pharmaceutical Solutions Phase 4
5 Anesthetics Phase 4
6 Narcotics Phase 4
7 Neurotransmitter Agents Phase 4
8 Hypnotics and Sedatives Phase 4
9 GABA Modulators Phase 4
10 Psychotropic Drugs Phase 4
11 Analgesics, Opioid Phase 4
12 Anesthetics, Intravenous Phase 4
13 Anesthetics, General Phase 4
14 Anti-Anxiety Agents Phase 4
15 Cola Phase 4
16 Immunoglobulins, Intravenous Phase 4
17 polysaccharide-K Phase 2, Phase 3
18
Heparin Approved, Investigational Phase 1, Phase 2 9005-49-6 772 9812414
19
Aluminum hydroxide Approved, Investigational Phase 2 21645-51-2
20
Bevacizumab Approved, Investigational Phase 2 216974-75-3
21 Antithrombins Phase 1, Phase 2
22 Liver Extracts Phase 1, Phase 2
23 Serine Proteinase Inhibitors Phase 1, Phase 2
24 Heparin Cofactor II Phase 1, Phase 2
25 Tissue Plasminogen Activator Phase 1, Phase 2
26 Antithrombin III Phase 1, Phase 2
27 Anticoagulants Phase 1, Phase 2
28 HIV Protease Inhibitors Phase 1, Phase 2
29
protease inhibitors Phase 1, Phase 2
30 calcium heparin Phase 1, Phase 2
31 N-(2-aminoethyl)-5-isoquinolinesulfonamide Phase 2
32 Antirheumatic Agents Phase 2
33 Adjuvants, Immunologic Phase 2
34 Interleukin-4 Phase 2
35 Hemagglutinins Phase 2
36 Muromonab-CD3 Phase 2
37 Mitogens Phase 2
38 Endothelial Growth Factors Phase 2
39
Serine Investigational, Nutraceutical Phase 1, Phase 2 56-45-1 5951
40
Kanamycin Approved, Investigational, Vet_approved Phase 1 59-01-8, 8063-07-8 6032
41
Palivizumab Approved, Investigational Phase 1 188039-54-5
42
Ibalizumab Approved, Investigational Phase 1 680188-33-4
43
nivolumab Approved Phase 1 946414-94-4
44
Cysteine Approved, Nutraceutical Phase 1 52-90-4 5862
45 Interleukin-2 Phase 1
46
rituximab Approved 174722-31-7 10201696
47
Racepinephrine Approved 329-65-7 838
48
Epinephrine Approved, Vet_approved 51-43-4 5816
49
Metronidazole Approved 443-48-1 4173
50
Methotrexate Approved 1959-05-2, 59-05-2 126941

Interventional clinical trials:

(show top 50) (show all 91)
# Name Status NCT ID Phase Drugs
1 Clinical Trial to Evaluate the Efficacy and Safety of SurgiFill™ on Spinal Fusion -Comparison Between Autograft Mixed With SurgiFill™ and Autograft in Spinal Fusion- Unknown status NCT02466048 Phase 4
2 Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study Unknown status NCT02651168 Phase 4
3 Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept Unknown status NCT03468296 Phase 4 Intravitreal Aflibercept Injection 2mg
4 Fentanyl Use for Sedation in Esophagogastroduodenoscopy (FUSE): a Phase 4, Randomized, Double-blind, Placebo-controlled Trial of Fentanyl Added to Midazolam Compared to Midazolam Alone for Sedation in Routine Upper Endoscopy Completed NCT01514695 Phase 4 Midazolam;Fentanyl
5 Single Center, Prospective, Open Label Post Marketing Study of EndoChoice's Fuse® Endoscopic System Performance In Routine Practice Completed NCT02439502 Phase 4
6 RCT Comparing i-FACTOR and Allograft in Spinal Fusion Surgery Completed NCT02895555 Phase 4
7 A Phase IV Randomised Clinical Trial of Laser Therapy for Peripheral Retinal Ischaemia Combined With Intravitreal Aflibercept (Eylea®) Versus Intravitreal Aflibercept Monotherapy for Diabetic Macular Oedema Active, not recruiting NCT02432547 Phase 4 Aflibercept
8 Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study Completed NCT01813773 Phase 2, Phase 3 Intravitreal Aflibercept Injection (IAI)
9 Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma (DOBL) - A Randomised Phase III Non- Inferiority Trial. Recruiting NCT02964858 Phase 3
10 A Randomized Phase II Study of Immunization Against Melanoma Comparing Autologous Dendritic Cells Pulsed With gp100 Peptide to Autologous Dendritic Cells Fused With Autologous Tumor Cells Unknown status NCT00085397 Phase 2
11 A Phase 1 / 2 Clinical Trial to Assess the Safety and Preliminary Efficacy of Lipoxin Analog BLXA4-ME Oral Rinse for the Treatment of Gingivitis Unknown status NCT02342691 Phase 1, Phase 2 BLXA4;Placebo oral rinse
12 A Phase I/II Study to Assess the Safety, Immunogenicity and Protective Efficacy of Novel Malaria Vaccine Candidates ChAdOx1 LS2 and MVA LS2 in Healthy UK Adults Completed NCT03203421 Phase 1, Phase 2
13 A Phase 2, Randomized, Open-label, Active Controlled, Dose Finding Study of Long-acting Hybrid Fc Fused Recombinant Human Growth Hormone (GX-H9) in Paeditaric Patients With Growth Hormone Deficiency Completed NCT03309891 Phase 2 GX-H9;Genotropin
14 A Randomized, Active-controlled, Multiple-dose, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of the Long-acting Antibody-fused Recombinant Human Growth Hormone (GX-H9) in Adult Growth Hormone Deficiency (AGHD) Completed NCT02946606 Phase 2 GX-H9;Genotropin
15 An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma Completed NCT02858895 Phase 2 MDNA55
16 A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases Completed NCT01227954 Phase 2
17 A Phase II, Open-label, Escalating Dose-ranging Study to Evaluate the Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults ≥65 Years of Age Completed NCT00966238 Phase 2
18 A Phase I/II Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Using the Intra-patient Escalation Dosing Regimen in Patients With Advanced Uveal Melanoma Active, not recruiting NCT02570308 Phase 1, Phase 2 IMCgp100
19 Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa Not yet recruiting NCT04658914 Phase 2
20 Safety, Immunogenicity, and Efficacy of R21/Matrix-M and ChAd63/MVA-ME-TRAP in the Context of Controlled Human Malaria Infection: A Phase IIb Trial in Kenyan Adults Not yet recruiting NCT03947190 Phase 2
21 A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer Who Have Failed First-Line Therapy Terminated NCT02045030 Phase 2 aflibercept + FOLFIRI
22 An Open-label, Multi-center, Rollover Study in Patients With Advanced Melanoma After Completing an IMCgp100 Clinical Study Terminated NCT02889861 Phase 2 IMCgp100
23 A Phase I/II Trial of CDX-1401 (a Vaccine Consisting of a Human Monoclonal Antibody Specific for DEC-205, Fused to Full-length Tumor Antigen NY-ESO-1) in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients Withdrawn NCT02661100 Phase 1, Phase 2 Pembrolizumab
24 Human OK99 Allogeneic Stem Cell Transplantation for Patients With Severe Parkinson's Disease Unknown status NCT02780895 Phase 1 Human Stem Cells
25 RV 151: A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine LFn-p24 Administered by the Intramuscular (IM) Route in Healthy Adults, WRAIR #984, HSRRB Log # A-11905. Completed NCT00412477 Phase 1
26 Phase I Study of Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Cancers Completed NCT02159716 Phase 1
27 A Phase 1 Double Blinded, Randomized, Placebo-controlled Dose Escalation Study to Examine the Safety, Reactogenicity, Tolerability and Immunogenicity of the P2-VP8 Subunit Rotavirus Vaccine in Healthy Adult Volunteers Completed NCT01764256 Phase 1
28 BION Stimulation to Improve Swallowing Function After Radical Head-neck Surgery and Follow-up Chemoradiation Therapy Completed NCT00628485 Phase 1
29 Restoration of Daily-life Hand Function Using a Brain/Neural-Computer Interaction (BNCI) System in Paralysis After Cervical Spinal Cord Injury Completed NCT02336321 Phase 1
30 Randomized, Placebo-controlled, Double-blind, Phase 1, Dose-escalating Study to Evaluate the Safety and Immunogenicity of a Synthetic Virus Like Particle (SVLP) Vaccine Against Respiratory Syncytial Virus (RSV) Recruiting NCT04519073 Phase 1
31 VRC 323: A Phase I Open-Label Clinical Trial to Evaluate the Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults Recruiting NCT04579250 Phase 1
32 A Phase I, Multicenter Study of CD4- Directed Chimeric Antigen Receptor Engineered T-cells (CD4CAR) in Patients With Relapsed or Refractory CD4+ Hematological Malignancies Recruiting NCT03829540 Phase 1
33 VRC 321: A Phase I Open-Label Clinical Trial to Evaluate Dose, Safety, Tolerability, and Immunogenicity of an Influenza H1 Stabilized Stem Ferritin Vaccine, VRCFLUNPF099-00-VP, in Healthy Adults Active, not recruiting NCT03814720 Phase 1
34 Phase Ib Study of Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases Active, not recruiting NCT03807765 Phase 1 Nivolumab
35 Treatment of Relapsed or Refractory Neuroblastoma With Ex-Vivo Expanded and Activated Haploidentical NK Cells and Hu14.18-IL2 Suspended NCT03209869 Phase 1
36 An Initial Feasibility Study to Integrate High-precision, Image Guided, Radiotherapy(MRI Based Brachytherapy and CT/MRI Fused Dynamic IMRT Planning) in the Treatment Planning of 10 Patients With Locally Advanced Carcinoma of the Cervix Withdrawn NCT01514955 Phase 1
37 BION Implantable Microstimulator System Withdrawn NCT00689286 Phase 1
38 A Study to Evaluate the Safety and Effectiveness of the TOPS™ SP System Unknown status NCT03247166
39 A Clinical Evaluation of Hand-veneered, Porcelain-fused NobelProcera(TM) Crown Shaded Zirconia and NobelProcera(TM) Full Contour Crown IPS e.Max CAD on Molars Unknown status NCT01835821
40 Assessment of Peri-Implant Tissues Surrounding PEEK and Porcelain Fused to Metal Superstructures in Posterior Region (Randomized Controlled Clinical Trial) Unknown status NCT03578913
41 The Influence of Porcelain Fused to Metal ( PFM) and Zirconia Crowns on Periodontal Health Unknown status NCT02461823
42 Web-based International Multi-Center Clinical Study for Parkinson's Disease; the Evaluation of Clinical Outcome Based on the Electrode Position Estimated From the Fused Images of Preoperative MRI and Postoperative CT After Bilateral STN DBS Unknown status NCT01696812
43 Evaluation of the Soft Tissue Stability Around Single Crowns Supported by Tissue Level Implants Placed in Non-augmented Healed Sites in the Anterior Maxilla: a Retrospective Study Unknown status NCT02061930
44 An Early Access Programme for Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia Approved for marketing NCT03501615 Moxetumomab Pasudotox
45 Post-bariatric Abdominoplasty: Skin Sensation Evaluation. Completed NCT00831610
46 Exploratory Study of Upper and Lower Endoscopic Fuse System Completed NCT02651857
47 A 4-arm Randomized Controlled Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy Completed NCT02345889
48 Randomized Multi-Center Post Market Clinical Study to Evaluate the Safety and Performance of NextraTM for Use in Foot Surgery to Fuse the Proximal-interphalangeal- Joints Completed NCT01604070
49 Full Spectrum vs. Standard Forward-viewing Colonoscopy With and Without Right-colon Retroflexion: a Randomized, Bicentric Back-to-back Study Completed NCT02117674
50 NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer Completed NCT02103634

Search NIH Clinical Center for Polykaryocytosis Inducer

Sources

Genetic Tests for Polykaryocytosis Inducer

About this section
Sources

Anatomical Context for Polykaryocytosis Inducer

About this section

MalaCards organs/tissues related to Polykaryocytosis Inducer:

40
Brain, Bone, Skeletal Muscle, Prostate, Liver, Heart, Bone Marrow
Sources

Publications for Polykaryocytosis Inducer

About this section

Articles related to Polykaryocytosis Inducer:

(show top 50) (show all 9871)
# Title Authors PMID Year
1
Gene assignment of a polykaryocytosis promoter (FUSE) to chromosome 10 in man. 61 57
752487 1978
2
COVID-19 classification by CCSHNet with deep fusion using transfer learning and discriminant correlation analysis. 61
33519321 2021
3
Alternative Seamless Cloning Strategies in Fusing Gene Fragments Based on Overlap-PCR. 61
33439452 2021
4
A novel method for identifying hotspots and forecasting air quality through an adaptive utilization of spatio-temporal information of multiple factors. 61
33246725 2021
5
Configural memory of a blending aromatic mixture reflected in activation of the left orbital part of the inferior frontal gyrus. 61
33358920 2021
6
Current patterns of practice in spinal fusion for chronic low back pain-results from a survey at the German Spine Societies' Annual Congress 2018. 61
33404879 2021
7
Mapping of the excitatory, inhibitory, and modulatory afferent projections to the anatomically defined active expiratory oscillator in adult male rats. 61
32656849 2021
8
Covid-19 classification by FGCNet with deep feature fusion from graph convolutional network and convolutional neural network. 61
33052196 2021
9
Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation. 61
33095259 2021
10
The pontine Kölliker-Fuse nucleus gates facial, hypoglossal, and vagal upper airway related motor activity. 61
33053424 2021
11
Image Fusion During Standard and Complex Endovascular Aortic Repair, to Fuse or Not to Fuse? A Meta-analysis and Additional Data From a Single-Center Retrospective Cohort. 61
32964768 2021
12
Super Resolution Infrared Thermal Imaging Using Pansharpening Algorithms: Quantitative Assessment and Application to UAV Thermal Imaging. 61
33578847 2021
13
Multi-Scale Frequency Bands Ensemble Learning for EEG-Based Emotion Recognition. 61
33578835 2021
14
Computer-aided diagnosis of ground glass pulmonary nodule by fusing deep learning and radiomics features. 61
33596552 2021
15
Somatic deficiency causes reproductive parasitism in a fungus. 61
33542245 2021
16
DIKA-Nets: Domain-invariant knowledge-guided attention networks for brain skull stripping of early developing macaques. 61
33338616 2021
17
Deep Coattention-Based Comparator for Relative Representation Learning in Person Re-Identification. 61
32275611 2021
18
Flagging fusion: Phosphatidylserine signaling in cell-cell fusion. 61
33581114 2021
19
Plant zygote development: recent insights and applications to clonal seeds. 61
33422964 2021
20
Potential Efficacy of Multimodal Mixed Reality in Epilepsy Surgery. 61
33382064 2021
21
A modular hierarchical array camera. 61
33602904 2021
22
Diversity and phylogeny of Paradiplozoon species (Monogenea: Diplozoidae) parasitising endemic cyprinoids in the peri-Mediterranean area, with a description of three new Paradiplozoon species. 61
33409627 2021
23
Accurate prediction of multi-label protein subcellular localization through multi-view feature learning with RBRL classifier. 61
33537726 2021
24
Spermatozoa morphology changes during reproduction and first observation of acrosomal contact in two dioecious species of Macrobiotidae (Tardigrada: Eutardigrada). 61
32914733 2021
25
Advances in the study of zygote activation in higher plants. 61
33054867 2021
26
RWSF-BLP: a novel lncRNA-disease association prediction model using random walk-based multi-similarity fusion and bidirectional label propagation. 61
33590345 2021
27
Reverse fountain flow of phosphatidylinositol-3,4-bisphosphate polarizes migrating cells. 61
33586225 2021
28
Novel insights into the development of the avian nasal cavity. 61
31872940 2021
29
PTPRJ promotes osteoclast maturation and activity by inhibiting Cbl-mediated ubiquitination of NFATc1 in late osteoclastogenesis. 61
33605542 2021
30
TGFβ signalling acts as a molecular brake of myoblast fusion. 61
33531476 2021
31
DeepIDA: predicting isoform-disease associations by data fusion and deep neural networks. 61
33571094 2021
32
Diatom-inspired self-assembly for silica thin sheets of perpendicular nanochannels. 61
33198979 2021
33
Sequential fusion of information from two portable spectrometers for improved prediction of moisture and soluble solids content in pear fruit. 61
33298261 2021
34
Virtual reality operating room with AI guidance: design and validation of a fire scenario. 61
32072293 2021
35
Using Chou's 5-Step Rule to Predict DNA-Protein Binding with Multi-scale Complementary Feature. 61
33522829 2021
36
Muscovy duck reovirus promotes virus replication by inhibiting autophagy-lysosomal degradation pathway. 61
33373883 2021
37
Mobile late endosomes modulate peripheral endoplasmic reticulum network architecture. 61
33554435 2021
38
The Association of Preoperative TNF-Alpha Inhibitor Use and Reoperation Rates in Spinal Fusion Surgery. 61
33545374 2021
39
No air without autophagy: autophagy is important for lung and swim bladder inflation. 61
33530832 2021
40
Multiview Diffusion Map Improves Prediction of Fluid Intelligence with Two Paradigms of fMRI Analysis. 61
33382644 2021
41
Chronic untreated retinal detachment in a patient with choroideremia provides insight into the disease process and potential therapy. 61
33573424 2021
42
See-Through Vision with Unsupervised Scene Occlusion Reconstruction. 61
33566758 2021
43
Attribute capture underlying the precedence effect in rats. 61
33212323 2021
44
Generation of Neurosphere-Derived Organoid-Like-Aggregates (NEDAS) from Neural Stem Cells. 61
33534198 2021
45
Cross-linking mass spectrometry uncovers protein interactions and functional assemblies in synaptic vesicle membranes. 61
33558502 2021
46
Cell-division pattern and phylogenetic analyses of a new ciliate genus Parasincirra n. g. (Protista, Ciliophora, Hypotrichia), with a report of a new soil species, P. sinica n. sp. from northwest China. 61
33568067 2021
47
Bioinspired multisensory neural network with crossmodal integration and recognition. 61
33602925 2021
48
DRCNN: Dynamic Routing Convolutional Neural Network for Multi-View 3D Object Recognition. 61
33237859 2021
49
Data-Level Recombination and Lightweight Fusion Scheme for RGB-D Salient Object Detection. 61
33201813 2021
50
A small-angle neutron scattering study of the physical mechanism that drives the action of a viral fusion peptide. 61
33253755 2021
Sources

Variations for Polykaryocytosis Inducer

About this section
Sources

Expression for Polykaryocytosis Inducer

About this section
Search GEO for disease gene expression data for Polykaryocytosis Inducer.
Sources

Pathways for Polykaryocytosis Inducer

About this section
Sources

GO Terms for Polykaryocytosis Inducer

About this section
Sources

Sources for Polykaryocytosis Inducer

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....